351 related articles for article (PubMed ID: 33069261)
1. Efficacy of orally and topically administered fluralaner (Bravecto
Chiummo R; Petersen I; Plehn C; Zschiesche E; Roepke R; Thomas E
Parasit Vectors; 2020 Oct; 13(1):524. PubMed ID: 33069261
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of fluralaner administered either orally or topically for the treatment of naturally acquired Sarcoptes scabiei var. canis infestation in dogs.
Taenzler J; Liebenberg J; Roepke RK; Frénais R; Heckeroth AR
Parasit Vectors; 2016 Jul; 9(1):392. PubMed ID: 27387742
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of a chewable tablet containing sarolaner, moxidectin, and pyrantel (Simparica Trio
Becskei C; Liebenberg J; Fernandes T; Borowski S; D'Hanis L; Mahabir SP
Parasit Vectors; 2023 Nov; 16(1):441. PubMed ID: 38012719
[TBL] [Abstract][Full Text] [Related]
4. Treatment of canine sarcoptic mange with afoxolaner (NexGard
Hampel V; Knaus M; Schäfer J; Beugnet F; Rehbein S
Parasite; 2018; 25():63. PubMed ID: 30516132
[TBL] [Abstract][Full Text] [Related]
5. Fluralaner as a novel treatment for sarcoptic mange in the bare-nosed wombat (Vombatus ursinus): safety, pharmacokinetics, efficacy and practicable use.
Wilkinson V; Takano K; Nichols D; Martin A; Holme R; Phalen D; Mounsey K; Charleston M; Kreiss A; Pye R; Browne E; Næsborg-Nielsen C; Richards SA; Carver S
Parasit Vectors; 2021 Jan; 14(1):18. PubMed ID: 33407820
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of a novel oral isoxazoline, sarolaner (Simparica™), for the treatment of sarcoptic mange in dogs.
Becskei C; De Bock F; Illambas J; Cherni JA; Fourie JJ; Lane M; Mahabir SP; Six RH
Vet Parasitol; 2016 May; 222():56-61. PubMed ID: 26928658
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy of orally administered fluralaner for treatment of scabies in six free-ranging raccoon dogs (Nyctereutes procyonoides).
Hyun JE; Jang HK; Hwang CY; Yeon SC
Vet Dermatol; 2019 Jun; 30(3):267-e81. PubMed ID: 30895701
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of fluralaner in 17 dogs with sarcoptic mange.
Romero C; Heredia R; Pineda J; Serrano JA; Mendoza GD; Trápala P; Cordero AM
Vet Dermatol; 2016 Oct; 27(5):353-e88. PubMed ID: 27511592
[TBL] [Abstract][Full Text] [Related]
9. A European field assessment of the efficacy of fluralaner (Bravecto
Petersen I; Chiummo R; Zschiesche E; Karas-Tecza J; Rapti D; Roepke R; Thomas E
Parasit Vectors; 2020 Jun; 13(1):304. PubMed ID: 32527282
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the in vitro acaricidal activity of Bravecto
Takano K; Carver S; Vermaak Y; Fischer K; Harvey RJ; Mounsey KE
Parasit Vectors; 2024 Apr; 17(1):194. PubMed ID: 38664829
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Fluralaner in the Treatment of Sarcoptic Mange (Sarcoptes scabiei) in 12 Pet Rabbits.
d'Ovidio D; Santoro D
Top Companion Anim Med; 2021 Jun; 43():100528. PubMed ID: 33548547
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of afoxolaner in a clinical field study in dogs naturally infested with Sarcoptes scabiei.
Beugnet F; de Vos C; Liebenberg J; Halos L; Larsen D; Fourie J
Parasite; 2016; 23():26. PubMed ID: 27317462
[TBL] [Abstract][Full Text] [Related]
13. Fluralaner 5.46% (w/w) flavored chewable tablet (Bravecto
Rohdich N; Meyer L; Guerino F
Parasit Vectors; 2022 Mar; 15(1):83. PubMed ID: 35279216
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of fluralaner against Otodectes cynotis infestations in dogs and cats.
Taenzler J; de Vos C; Roepke RK; Frénais R; Heckeroth AR
Parasit Vectors; 2017 Jan; 10(1):30. PubMed ID: 28093080
[TBL] [Abstract][Full Text] [Related]
15. A randomized, blinded, controlled and multi-centered field study comparing the efficacy and safety of Bravecto (fluralaner) against Frontline (fipronil) in flea- and tick-infested dogs.
Rohdich N; Roepke RK; Zschiesche E
Parasit Vectors; 2014 Mar; 7():83. PubMed ID: 24593931
[TBL] [Abstract][Full Text] [Related]
16. Effective treatment of sarcoptic mange in an alpaca (Vicugna pacos) using fluralaner: a case report.
Sala G; Gazzonis AL; Pravettoni D; Cafiso A; Grilli G; Ferrulli V; Boccardo A; Di Cesare F; Pavesi LF; Zanzani S
Vet Res Commun; 2024 Jun; 48(3):1837-1843. PubMed ID: 38280082
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effects of oral fluralaner in pet rabbits with severe sarcoptic mange (Sarcoptes scabiei).
Singh SK; Jaiswal AK; Kumari S; Gaur RS; Sharma P; Khushboo R; Jaiswal M
Vet Parasitol; 2022 Apr; 304():109693. PubMed ID: 35276384
[TBL] [Abstract][Full Text] [Related]
18. The most effective systemic treatment in dogs with sarcoptic mange: a critically appraised topic.
Dumitrache MO; Cadiergues MC
BMC Vet Res; 2023 Oct; 19(1):189. PubMed ID: 37798627
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of a novel formulation of metaflumizone plus amitraz for the treatment of sarcoptic mange in dogs.
Fourie LJ; Kok DJ; du Plessis A; Rugg D
Vet Parasitol; 2007 Dec; 150(3):275-81. PubMed ID: 17931787
[TBL] [Abstract][Full Text] [Related]
20. A quantitative evaluation of the extent of fluralaner uptake by ticks (Ixodes ricinus, Ixodes scapularis) in fluralaner (Bravecto) treated vs. untreated dogs using the parameters tick weight and coxal index.
Williams H; Demeler J; Taenzler J; Roepke RK; Zschiesche E; Heckeroth AR
Parasit Vectors; 2015 Jun; 8():352. PubMed ID: 26123249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
